A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus
Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and
‘Breakthrough’ infections can happen because of waning immunity or high viral doses. But our vaccines are still excellent at preventing severe disease and death